5 completed, 2 recruiting, 2 terminated, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Terminated 1 |
Follow ACEI: new trials by email Literature Review of ACEI trials Research Report on ACEI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk Beta Blocker, ACE inhibitor, Calcium channel blocker - Hypertension, Fall Risk | Not applicable | Recruiting | Abant Izzet Baysal University | 186 | 2025-08-01 | 2026-02-12 |
| Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection Antihistamine, Amantadine, ACEI - COVID19, Influenza Vaccination | Recruiting | Consorci Sanitari de Terrassa | 3000 | 2020-03-01 | 2026-03-25 | |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT Beta blocker, ACEI, ARB - Myocardial Infarction With Non-obstructive Coronary Arteries | Phase 4 | Terminated | Uppsala University | 198 | 2018-12-16 | 2023-11-27 |
| The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children Prednisone, ACEI - Henoch-Schoenlein Purpura Nephritis | Phase 2 | Unknown | Nanjing Children's Hospital | 100 | 2015-08-01 | 2020-02-26 |
| SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World guideline adherence - Heart Failure, Congestive | Completed | GlaxoSmithKline | 1 | 2011-03-01 | 2012-11-30 | |
| The Use of Angiotensin Receptor Blockers and the Risk of Cancer ARB, ACEI, Beta-blockers - Neoplasm | Completed | Boehringer Ingelheim | 1165781 | 2011-02-01 | 2014-08-13 | |
| Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts tacrolimus, Simulect, Cellcept - Kidney Transplantation | Phase 3 | Completed | Astellas Pharma Inc | 281 | 2009-08-17 | 2024-11-01 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy Mycophenolate Mofetil (MMF), MMF Placebo, ACEi - IgA Nephropathy | Phase 3 | Terminated | St. Joseph's Hospital and Medical Center, Phoenix | 184 | 2002-01-01 | 2016-03-07 |
| African American Study of Kidney Disease and Hypertension MAP goal less than or equal to 92 mm Hg, MAP goal 102-107 mm Hg, Ramipril - Hypertensive Nephrosclerosis, Chronic Renal Insufficiency | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1094 | 1995-02-01 | 2020-04-27 |
Hypertension (2) · COVID-19 (1) · Glomerulonephritis, IGA (1) · Heart Failure (1) · Heart Failure, Systolic (1) · Influenza, Human (1) · MINOCA (1) · Myocardial Infarction (1) · Neoplasms (1) · Proteinuria (1) · Renal Insufficiency, Chronic (1)
Abant Izzet Baysal University (1) · Astellas Pharma Inc (1) · Boehringer Ingelheim (1) · Consorci Sanitari de Terrassa (1) · GlaxoSmithKline (1) · Nanjing Children's Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · St. Joseph's Hospital and Medical Center, Phoenix (1) · University of Utah (1) · Uppsala University (1)
Spain (2) · United States (2) · Australia (1) · Canada (1) · China (1) · New Zealand (1) · Norway (1) · South Korea (1) · Sweden (1) · Turkey (Türkiye) (1)
Adam P Bress, PharmD, MS (1) · Aihua Zhang, M.D. (1) · Alp Ozel, PT, PhD (1) · Bertil Lindahl, Prof (1) · Ronald J Hogg, M.D. (1)
PMID 11386927, PMID 12435255, PMID 20818902, PMID 30582281, PMID 33203618, PMID 33891615, PMID 36853224, PMID 38299639, PMID 38864363, PMID 39082471, PMID 39459868, PMID 39739990, PMID 40508884, PMID 41198855, PMID 42246870
U01DK048648 (1)